share_log

海森药业(001367.SZ):公司有产品涉及使用酶催化反应等生物合成相关技术

Hisense Pharmaceutical (001367.SZ): The company has products involving the use of biosynthesis related technologies such as enzymatic catalytic reactions

Gelonghui Finance ·  May 6 19:35

Gelonghui, May 7 | Hisense Pharmaceutical (001367.SZ) said on the investor interactive platform that the company has products involving the use of biosynthesis-related technologies such as enzymatic catalytic reactions. This technology has the advantages of high stereoselectivity, mild reaction conditions, good environmental protection, and low comprehensive cost. In order to further enhance the wide application of related technologies in production, the company cooperated with the Jinhua Research Institute of Zhejiang University and others, and related research work is being actively promoted.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment